DNAPrint Pharmaceuticals To Present At New York Life Sciences Venture Summit

Published: Oct 20, 2006

SARASOTA, FL -- (MARKET WIRE) -- October 20, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that Chairman and Chief Medical Officer Hector J. Gomez, M.D., Ph.D., will present an overview of the Company's subsidiary, DNAPrint Pharmaceuticals, at The 2006 Life Sciences Venture Summit on Wednesday, October 25, at the New Yorker Hotel, Eighth Ave. at 34th St., in New York City.

Back to news